What is Minivelle
EstradiolThe Generic name of this drug
Treatment SummaryEstradiol is a hormone found naturally in female bodies. It is commonly used as a form of hormone therapy to manage conditions caused by low estrogen levels, such as hot flashes and vulvovaginal atrophy. Estradiol can be taken in many forms, including pills, injections, vaginal rings, patches, sprays, gels, and creams. For oral or IM administration, estradiol is usually combined with a pro-drug ester. The synthetic form of estradiol called ethinyl estradiol (EE) is commonly used in combination oral contraceptive pills (OCPs). EE is more bio
Estradermis the brand name
Minivelle Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Estraderm
Estradiol
1986
373
Approved as Treatment by the FDA
Estradiol, also known as Estraderm, is approved by the FDA for 4 uses like Palliative Treatment and Birth Control .Palliative Treatment
Birth Control
Used to treat Contraception in combination with Levonorgestrel
Hormonal Contraception
Used to treat Hormonal Contraception therapy in combination with Levonorgestrel
Breast Cancer
Effectiveness
How Minivelle Affects PatientsEstradiol helps to reduce hot flashes, vaginal dryness, and pain during sex. Additionally, it can help to strengthen bones by stopping bone breakdown and improve the levels of good cholesterol in the body. It can also increase the production of certain proteins like sex hormone binding globulin, and thyroid-binding globulin, and reduce production of follicle-stimulating hormone. Unfortunately, estradiol may increase the risk of cardiovascular disease, blood clots, and stroke in some people, and should be avoided if you have a higher risk of these conditions. It can also cause an increase in blood pressure by making your body retain more
How Minivelle works in the bodyEstrogen is a hormone found in the breast, uterus, ovaries, skin, prostate, bone, fat, and brain. In pre-menopausal women, the ovaries produce most of the estrogen in the body. After menopause, the majority of estrogen is produced by the transformation of androstenedione (a hormone from the adrenal cortex) into estrone in other areas of the body. Estrogen works by binding to two types of receptors: alpha and beta. When estrogen binds to these receptors, it sends a signal to the nucleus of the cell to produce specific proteins that cause the desired effect. In post-
When to interrupt dosage
The measure of Minivelle is subject to the diagnosed condition, for instance Premature Menopause, Pharmaceutical Preparations and Postmenopause. The measure of dosage fluctuates in accordance with the application approach specified in the table below.Condition
Dosage
Administration
Kraurosis Vulvae
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
advanced androgen dependent Prostate cancer
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
estradiol
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
moderate to severe symptoms
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
Urogenital atrophy
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
Hormone Replacement Therapy
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
Breast
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
no menstrual period in previous 6 months
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
Osteoporosis
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
Postmenopausal Osteoporosis
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
Hypogonadism
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
Premature Menopause
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
Birth Control
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
Pharmaceutical Preparations
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
Prostate Cancer
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
Hot flashes
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
Atrophic
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
Hormonal Contraception
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
Vasomotor System
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
female castration
0.005 mg/hour, 0.00025 mg/mg, , 0.06 %, 0.001 mg/mg, 3.28 mg, 0.0025 mg/mg, 0.0025 mg/hour, 2.0 mg, 2.17 mg, 0.5 mg, 0.00375 mg/hour, 0.01 mg/hour, 0.0075 mg/hour, 1.0 mg, 6.0 mg, 12.5 mg, 18.0 mg, 20.0 mg, 15.0 mg, 25.0 mg, 10.0 mg, 22.0 mg, 0.005 mg/mg, 6.57 mg, 0.00125 mg/mg, 0.0075 mg/mg, 0.025 mg, 0.00075 mg/mg, 8.0 mg, 0.097 mg/[USP'U], 0.01 mg/[USP'U], 4.0 mg, 0.0001 mg/mg, 0.00005 mg/mg, 5.0 mg, 1.5 mg, 0.00052 mg/mg, 0.004 mg, 0.01 mg, 0.0005 mg/mg, 0.0006 mg/mg, 0.006 mg/hour, 1.53 mg, 0.1 %, 20.0 mg/mL, 8.66 mg, 4.33 mg, 6.56 mg, 0.146 mg/[USP'U], 4.4 mg, 5.0 mg/mL, 0.0014 mg/hour, 0.62 mg, 40.0 mg/mL, 0.194 mg/[USP'U], 0.0045 mg/hour, 0.0052 mg/mg, 0.05 mg, 10.0 mg/mL, 0.51 mg, 0.45 mg, 2.5 mg/mL, 1.8 mg, 0.9 mg, 4.84 mg, 14.0 mg, 4.95 mg, 50.0 mg
Transdermal, , Tablet, film coated, Insert - Vaginal, Tablet - Oral, Patch, extended release - Transdermal, Patch - Transdermal, Patch, Oral, Oral; Transdermal, Capsule; Kit, Vaginal, Patch, extended release, Tablet, Kit; Tablet - Oral, Insert, Gel - Transdermal, Topical, Spray, Cream - Vaginal, Capsule, Gel, Capsule; Spray, metered, Capsule; Kit - Oral, Tablet, film coated - Oral, Kit; Tablet, Film, extended release, Gel - Topical, Gel, metered, Ring - Vaginal, Spray - Transdermal, Tablet - Vaginal, Emulsion - Topical, Cream, Pellet - Oral, Pellet, Film, extended release - Transdermal, Capsule; Spray, metered - Oral; Transdermal, Emulsion, Lotion - Topical, Capsule - Oral, Gel, metered - Topical, Tablet, film coated - Vaginal, Spray, metered, Spray, metered - Transdermal, Ring, Gel, metered - Transdermal, Injection - Intramuscular, Intramuscular, Cream - Transdermal, Pellet, implantable - Subcutaneous, Injection, solution - Intramuscular, Pellet, implantable
Warnings
Minivelle ContraindicationsCondition
Risk Level
Notes
Deep Vein Thrombosis
Do Not Combine
Thromboembolism
Do Not Combine
Pulmonary Embolism
Do Not Combine
Thromboembolism
Do Not Combine
Neoplasms, Hormone-Dependent
Do Not Combine
undiagnosed abnormal genital bleeding
Do Not Combine
Liver Dysfunction
Do Not Combine
Thrombophilia
Do Not Combine
Breast
Do Not Combine
Breast
Do Not Combine
Angioedema
Do Not Combine
Breast Cancer
Do Not Combine
history of deep venous thrombosis
Do Not Combine
Pulmonary Embolism
Do Not Combine
Angioedema
Do Not Combine
estrogen-dependent neoplasia
Do Not Combine
suspected pregnancy
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Estradiol may interact with Toxoplasma Infections
Common Minivelle Drug Interactions
Drug Name
Risk Level
Description
Aminophylline
Major
The metabolism of Aminophylline can be decreased when combined with Estradiol.
Anagrelide
Major
The metabolism of Anagrelide can be decreased when combined with Estradiol.
Anastrozole
Major
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estradiol.
Astemizole
Major
The metabolism of Astemizole can be decreased when combined with Estradiol.
Axitinib
Major
The metabolism of Axitinib can be decreased when combined with Estradiol.
Minivelle Toxicity & Overdose RiskResearch has found that the highest safe dose of estradiol is 0.003mg/kg per day after 90 days in rats. The lethal dose of estradiol is 960mg/kg in rats. If someone overdoses on estradiol, they may experience nausea, vomiting, abdominal pain, breast tenderness, blood clots, and vaginal bleeding. In the case of an overdose, it is advised to discontinue estradiol treatment and provide supportive care.
Minivelle Novel Uses: Which Conditions Have a Clinical Trial Featuring Minivelle?
867 active studies are currently examining the potential of Minivelle to treat Osteoporosis, Absence of Menstruation in the Last 6 Months and Urogenital Atrophy.Condition
Clinical Trials
Trial Phases
Osteoporosis
44 Actively Recruiting
Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 4, Phase 3
Metastatic Breast Cancer
89 Actively Recruiting
Phase 2, Phase 1, Phase 3, Not Applicable, Phase 4
Birth Control
37 Actively Recruiting
Not Applicable, Phase 4, Early Phase 1, Phase 3, Phase 2, Phase 1
Urogenital atrophy
0 Actively Recruiting
Postmenopausal Osteoporosis
3 Actively Recruiting
Phase 4, Not Applicable, Phase 3
Hot flashes
20 Actively Recruiting
Phase 2, Not Applicable, Phase 1, Phase 4, Early Phase 1
Hypogonadism
0 Actively Recruiting
Hormone Replacement Therapy
0 Actively Recruiting
Atrophic
4 Actively Recruiting
Phase 4, Phase 2, Not Applicable
no menstrual period in previous 6 months
0 Actively Recruiting
Postmenopause
7 Actively Recruiting
Phase 2, Not Applicable, Phase 3
moderate to severe symptoms
0 Actively Recruiting
Low Testosterone
21 Actively Recruiting
Phase 1, Not Applicable, Phase 4, Phase 2
Hysterectomy
2 Actively Recruiting
Not Applicable, Phase 4
Vasomotor Symptoms Associated With Menopause
5 Actively Recruiting
Phase 3
Hormonal Contraception
0 Actively Recruiting
Kraurosis Vulvae
0 Actively Recruiting
Breast Cancer
692 Actively Recruiting
Phase 1, Phase 2, Phase 3, Not Applicable, Early Phase 1, Phase 4
Premature Menopause
0 Actively Recruiting
Breast
0 Actively Recruiting
Minivelle Reviews: What are patients saying about Minivelle?
5Patient Review
10/28/2014 This medication quickly and effectively stopped my hot flashes and mood swings. I haven't experienced any negative side effects, so I would recommend it to anyone else dealing with menopause symptoms.
5Patient Review
3/10/2017 I've been using this product for almost a decade now and have never had any issues.
5Patient Review
6/22/2021 I've been using this patch for five years, since I entered menopause at age thirty-nine. The generic pills and patches made me so sick that I couldn't even get out of bed. My insurance has never covered them. There are ninety-day cycles where I've paid as much as $800 for them. I don't care how much they cost as long as I don't have the symptoms of menopause. This patch saved my life!
4Patient Review
3/2/2016 I had some intense joint pain and other menopause-related issues, but this treatment really helped. It's been eighteen months now and I've seen a remarkable improvement. The only downside is that the adhesive sometimes gets on my clothes; otherwise, it does a good job of staying put.
3.3Patient Review
2/20/2018 I had a good first month with Minivelle, but the second month I developed an allergic reaction to the patch in the form of itchy red circles. The drug representative suggested waving the patch around for 30 seconds before applying, to evaporate the alcohol; however, this only made my reaction worse. Looks like I'll have to try something else.
3Patient Review
9/24/2019 I took this treatment for several years and it did help with my menopausal symptoms like night sweats and insomnia. However, I now have breast cancer and regret ever taking the medication. It's also brought back the sweats, but now they're all day and all night long.
2.7Patient Review
9/29/2016 I tried switching from Vivelle Dot Patch to Minivelle. It stays on better but does not work as well as the full size patch. On the Minivelle I am now having hot flashes, low mood, tired and delicate and dry skin issues. I will be going back to the brand name Vivelle Dot Patch as soon as possible.
1.3Patient Review
10/30/2014 The patch is Terrible! Sticks to my clothes and falls off after only 2 days. I am supposed to wear it for 4 days. Vivelle was much better in comparison; it actually stayed on and did its job.
1Patient Review
8/20/2015 I had a really terrible experience with this brand last month. The pharmacist switched me from Vivelle dot to Minivelle, and I immediately regretted it. I experienced headaches, fatigue, and an literal burning sensation on my skin where the patch was located. I would highly recommend avoiding this medication if at all possible.
1Patient Review
4/4/2018 I've been using Vivelle for 18 years, and only switched to Minivelle because of insurance. It's an awful drug that has made me gain a lot of weight, my breasts are sensitive and enlarged, and I have aches all over my body.
Patient Q&A Section about minivelle
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is the generic for MINIVELLE?
"The name of the medication is Estradiol and it is available in different dosages including 0.025mg/day, 0.0375mg/day, 0.05mg/day, 0.075mg/day, and 0.1mg/day. The medication is applied to the skin in the form of a transdermal system."
Answered by AI
Is MINIVELLE the same as estradiol?
"Minivelle is a form of the female hormone estrogen that is used to treat moderate to severe vasomotor symptoms that are caused by menopause."
Answered by AI
What is MINIVELLE used for?
"This medication acts as a female hormone replacement and helps to ease menopausal symptoms such as hot flashes and vaginal dryness that are caused by the body's decreased production of estrogen."
Answered by AI
Is MINIVELLE the same as Vivelle-Dot?
"The Vivelle-Dot is an estrogen patch that is said to be easier and more convenient to use than the pill or gel form. This patch is also used to relieve menopause symptoms. The Minivelle is a mini-me of the Vivelle-Dot. It is used twice a week and is available in five strengths. The Minivelle is also said to have less skin irritation."
Answered by AI